R848

DRUG3 trials

Sponsors

Imperial College London, Cambridge University Hospitals NHS Foundation Trust, Akhilesh Jha

Conditions

Allergic RhinitisAsthmaInnate ImmunityInnate Inflammatory ResponseLatent TuberculosisMucosal ImmunityNasal AllergyViral Infection

Unknown Phase

Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen

CompletedNCT02090374

Imperial College LondonAllergic Rhinitis, Asthma, Latent Tuberculosis

Start: 2014-03-31End: 2017-03-31Updated: 2021-11-05

Nasal Immune Challenge Study

Cambridge University Hospitals NHS Foundation TrustAsthma, Innate Inflammatory Response, Nasal Allergy

Start: 2022-08-09End: 2024-09-30Target: 24Updated: 2023-09-01

Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)

RecruitingNCT06488118

Akhilesh JhaAsthma, Innate Immunity, Mucosal Immunity +1

Start: 2024-05-24End: 2025-07-31Target: 36Updated: 2024-07-10